EyePoint Pharmaceuticals, Inc. financial statements, including revenue, expenses, profit, and loss
The total revenue of EYPT for the last quarter is 14.03 M USD, and it's 7.72% lower compared to the previous quarter. The net income of Q4 23 is -14.10 M USD.